Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Molecular and Clinical Oncology|February 19, 2021
Safety of same-day administration of gemcitabine plus cisplatin chemotherapy for urothelial carcinomaIbuki Tsuru, Fusako Niimi, Sachi Honda, et al.
GHM Open|March 27, 2025
Do hilar clamping and renorrhaphy influence postoperative renal function after partial nephrectomy?Masaki Nakamura, Ibuki Tsuru, Yoshiyuki Shiga, et al.
Global Health & Medicine|March 3, 2023
Trends in surgical treatment for prostate cancer: Analysis of National Database Open Data in JapanMasaki Nakamura, Motofumi Suzuki, Taro Izumi, et al.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|January 20, 2022
[A CASE OF IgG4-RELATED DISEASE OF THE URETER DIAGNOSED BY TRANSVAGINAL ULTRASOUND-GUIDED BIOPSY]Hideyuki Kondo, Akira Ishikawa, Ibuki Tsuru, et al.
Urology Case Reports|January 3, 2022
A case of cystic mucinous adenocarcinoma of the prostate treated by robot-assisted radical prostatectomyToyoshi Seito, Akira Ishikawa, Ibuki Tsuru, et al.
IJU Case Reports|September 3, 2024
A giant pelvic arteriovenous malformationTaro Izumi, Marie Osawa, Ibuki Tsuru, et al.
Oncology Letters|March 19, 2019
Metastatic renal cell carcinoma regains sensitivity to tyrosine kinase inhibitor after nivolumab treatment: A case reportTakeshi Azuma, Tohru Sugihara, Sachi Honda, et al.
Transplantation Proceedings|March 30, 2023
Bladder Preservation After Bilateral Kidney Loss and Bladder Cancer After Renal Transplantation: A Case ReportToyoshi Seito, Akira Ishikawa, Ibuki Tsuru, et al.
European Urology Focus|April 19, 2026
Consolidative Surgery for Advanced Upper Urinary Tract Urothelial Carcinoma After Enfortumab Vedotin and/or Immune Checkpoint InhibitorsSatoru Taguchi, Michinori Shimizu, Ibuki Tsuru, et al.
Pageof 3